The society of nuclear medicine and Molecular Imaging (SNMMI) announced a new slate of officers during its 2019 Annual Meeting, in Anahaeim, California. Alan B. Packard, PhD, and Richard L. Wahl, MD, were elected the 2019–2020 President-Elect and Vice President-Elect, respectively.
Alan B. Packard, PhD, President-Elect
Dr. Packard is Associate Professor of Radiology at Harvard Medical School, Director of Radiopharmaceutical Research and a Senior Research Associate in Nuclear Medicine at Boston Children’s Hospital, and Research Associate in Nuclear Medicine at
Alan B. Packard, PhD
Brigham and Women’s Hospital in Boston.He explained that his overall goal for the coming year is to enhance the value of SNMMI membership. He plans to accomplish this by working to enhance the society’s core member benefits—the SNMMI Annual Meeting, continuing education, The Journal of Nuclear Medicine—and by strengthening the society and nuclear medicine more broadly through the SNMMI Value Initiative. This initiative is SNMMI’s strategic vision for working with industry and other partners to demonstrate the crucial role of nuclear medicine and molecular imaging to the medical community, regulators, patients, and the public.
Richard L. Wahl, MD, Vice President-Elect
Richard L. Wahl, MD, was elected the 2019–2020 Vice President-Elect.Dr. Wahl is the Elizabeth E. Mallinckrodt Professor and
Richard L. Wahl, MD
Head of Radiology at Washington University School of Medicine in St. Louis, Director of the University’s Mallinckrodt Institute of Radiology, and Professor of Radiation Oncology.
In his years in office, Dr. Wahl plans to focus on advocacy for nuclear medicine, enhancing the number of professionals working in nuclear medicine, and discovery and innovation. Dr. Wahl currently serves as the Chair of the Research and Discovery domain for the society’s Value Initiative. He has served on the editorial board of The Journal of Nuclear Medicine for many years. ■
